SMH Oncology Counselor Recognized for Care and Compassion to Cancer Patients

SMH Oncology Counselor Recognized for Care and Compassion to Cancer Patients

An oncology counselor with Sarasota Memorial’s Brian D. Jellison Cancer Institute has been recognized for decades of extraordinary dedication and care for cancer patients

Tuesday, November 25, 2025
Sarasota Memorial’s Brian D. Jellison Cancer Institute Named Center of Excellence for  Lung Cancer Detection & Care

Sarasota Memorial’s Brian D. Jellison Cancer Institute Named Center of Excellence for Lung Cancer Detection & Care

The Brian D. Jellison Cancer Institute team has been nationally recognized for catching early-stage lung cancer at double the rate achieved in most health systems across the nation. 

Thursday, November 20, 2025
Donors, Doctors, Staff Inscribe Messages of Hope, Healing for Future Patients of SMH’s New Cancer Pavilion

Donors, Doctors, Staff Inscribe Messages of Hope, Healing for Future Patients of SMH’s New Cancer Pavilion

Dozens of donors, doctors, staff and leaders of Sarasota Memorial Health Care System’s Brian D. Jellison Cancer Institute left their mark Friday on SMH’s newest cancer facility – the Milman-Kover Cancer Pavilion. The new outpatient facility is slated to open early next year on SMH's Sarasota campus.

Monday, June 16, 2025
SMH Cancer Specialists Using AI-Driven, 3D Imaging to Improve Surgical Outcomes for Cancer Patients

SMH Cancer Specialists Using AI-Driven, 3D Imaging to Improve Surgical Outcomes for Cancer Patients

Surgeons with Sarasota Memorial’s Brian D. Jellison Cancer Institute are using AI-powered, 3D surgical imaging to enhance precision and improve outcomes for cancer patients

Thursday, May 15, 2025
Sarasota Memorial Joins Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer

Sarasota Memorial Joins Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer

In an effort to improve treatment outcomes, Sarasota Memorial’s Brian D. Jellison Cancer Institute and research team are part of a clinical trial investigating a novel therapy formulated to overcome the resistance to treatment that can build up in late-stage ovarian cancer patients. 

Wednesday, April 2, 2025
RSS
12345